AMPE
Ampio Pharmaceuticals Inc.
AMPE
AMPE
Delisted
AMPE was delisted on the 12th of April, 2024.
64 hedge funds and large institutions have $9.82M invested in Ampio Pharmaceuticals Inc. in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
23% less capital invested
Capital invested by funds: $12.8M → $9.82M (-$2.97M)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Holders
64
Holding in Top 10
1
Calls
$72K
Puts
$41K
Top Buyers
| 1 | +$2.64M | |
| 2 | +$50K | |
| 3 | +$26K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$22.5K |
| 5 |
Goldman Sachs
New York
|
+$17K |
Top Sellers
| 1 | -$1.3M | |
| 2 | -$70K | |
| 3 | -$63.7K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$63.7K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$49K |